Single-cell and spatial transcriptomics reveal a DLL4-associated tip-like endothelial niche linked to neoadjuvant chemotherapy non-response in muscle-invasive bladder cancer.
5 affiliations
- 1Department of Urology, Clinical Medical College of Shanghai Tenth People's Hospital, Nanjing Medical University, Shanghai, China.
- 2Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- 3Key Laboratory of Cancer Prevention and Treatment of Guizhou Province, Zunyi Medical University, Zunyi, 563000, China.
- 4Department of Pathology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: [email protected].
- 5Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: [email protected].
Abstract
Chemotherapy non-response remains a major challenge in bladder cancer, yet the endothelial states and intercellular communication programs associated with treatment failure remain poorly understood. Here, we integrated single-cell RNA sequencing, spatial transcriptomics, bulk transcriptomic data, computational analyses, and in vitro experiments to characterize endothelial programs associated with chemotherapy response. A non-response-related transcriptional program was preferentially enriched in endothelial cells and was most prominent in the TipEC_2 tip-like endothelial subset. Integrative analyses identified DLL4 as a key feature of this endothelial state. Spatial and ligand-receptor analyses further supported a DLL4-associated tip-like endothelial niche and inferred DLL4-NOTCH3-related communication between endothelial and malignant compartments, together with RBPJ-associated transcriptional activity in DLL4-positive TipEC_2 cells. Consistently, cisplatin-resistant bladder cancer cells showed increased expression of NOTCH3 and downstream transcriptional targets, whereas pharmacological Notch inhibition suppressed downstream HES1 and HEY1 expression and partially restored cisplatin sensitivity. Elevated DLL4 expression was associated with chemotherapy non-response and unfavorable survival. In a separate prognostic analysis, a DLL4-positive TipEC_2-associated risk model stratified patients by overall survival in TCGA-BLCA and GSE13507. Collectively, these findings identify a DLL4-associated tip-like endothelial niche linked to chemotherapy non-response and suggest DLL4-NOTCH3 signaling as a potential molecular link between vascular remodeling and treatment resistance in bladder cancer.
Related
- Genomic alterations associated with response to neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma.
- Early Change in the Pan-Immune-Inflammation Value During Neoadjuvant Chemotherapy Is Associated with Pathological Complete Response in HER2-Positive and Triple-Negative Breast Cancer: A Single-Centre Study with Temporal Validation
- Correlation of Axillary Nodal with Breast Response Following Neoadjuvant Chemotherapy in Early Breast Cancer
- 142 DCE-MRI radiogenomics predicts immune microenvironment subtypes and neoadjuvant chemotherapy response in HR+/HER2− breast cancer
- Relative change rate of neutrophil-to-albumin ratio (ΔNAR) during neoadjuvant chemotherapy predicts axillary pathological complete response in locally advanced breast cancer
BibTeX
@article{pan2026singlecell,
title = {{Single-cell and spatial transcriptomics reveal a DLL4-associated tip-like endothelial niche linked to neoadjuvant chemotherapy non-response in muscle-invasive bladder cancer.}},
author = {Bochen Pan and Jiadong Zheng and Zuchao Luo and Shihao Hou and Caijun Yuan and Yang Wang and Xiangqian Cao and Letong Huang and Man Li and Haoyuan Wang and Bing Shen},
journal = {Translational oncology},
year = {2026},
month = oct,
doi = {10.1016/j.tranon.2026.103067},
url = {https://europepmc.org/article/MED/42874537},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Single-cell and spatial transcriptomics reveal a DLL4-associated tip-like endothelial niche linked to neoadjuvant chemotherapy non-response in muscle-invasive bladder cancer.
AU - Bochen Pan
AU - Jiadong Zheng
AU - Zuchao Luo
AU - Shihao Hou
AU - Caijun Yuan
AU - Yang Wang
AU - Xiangqian Cao
AU - Letong Huang
AU - Man Li
AU - Haoyuan Wang
AU - Bing Shen
PY - 2026
DA - 2026/10/14
JO - Translational oncology
DO - 10.1016/j.tranon.2026.103067
UR - https://europepmc.org/article/MED/42874537
AB - Chemotherapy non-response remains a major challenge in bladder cancer, yet the endothelial states and intercellular communication programs associated with treatment failure remain poorly understood. Here, we integrated single-cell RNA sequencing, spatial transcriptomics, bulk transcriptomic data, computational analyses, and in vitro experiments to characterize endothelial programs associated with chemotherapy response. A non-response-related transcriptional program was preferentially enriched in endothelial cells and was most prominent in the TipEC_2 tip-like endothelial subset. Integrative analyses identified DLL4 as a key feature of this endothelial state. Spatial and ligand-receptor analyses further supported a DLL4-associated tip-like endothelial niche and inferred DLL4-NOTCH3-related communication between endothelial and malignant compartments, together with RBPJ-associated transcriptional activity in DLL4-positive TipEC_2 cells. Consistently, cisplatin-resistant bladder cancer cells showed increased expression of NOTCH3 and downstream transcriptional targets, whereas pharmacological Notch inhibition suppressed downstream HES1 and HEY1 expression and partially restored cisplatin sensitivity. Elevated DLL4 expression was associated with chemotherapy non-response and unfavorable survival. In a separate prognostic analysis, a DLL4-positive TipEC_2-associated risk model stratified patients by overall survival in TCGA-BLCA and GSE13507. Collectively, these findings identify a DLL4-associated tip-like endothelial niche linked to chemotherapy non-response and suggest DLL4-NOTCH3 signaling as a potential molecular link between vascular remodeling and treatment resistance in bladder cancer.
SN - 1936-5233
ER -